Pharm Tech Minutes 2022.02.04: Difference between revisions

From IHE Wiki
Jump to navigation Jump to search
← Older edit
Michael tan (talk | contribs)
2,698 edits
Michael tan (talk | contribs)
2,698 edits
 
(5 intermediate revisions by the same user not shown)
Line 23: Line 23:




* Strategy and stakeholder discussion
===Strategy and stakeholder discussion===
** Could the patient be a stakeholder? The aim is to improve the quality of information.
* Could the patient be a stakeholder? The aim is to improve the quality of information.
** In Netherlands a patient program called MedMij is available. This is not centralized. But PHR can certify against FHIR profiles.
** In Netherlands a patient program called MedMij is available. This is not centralized. But PHR can certify against FHIR profiles.
** In Belgium patients already have an individual PHR which contains partially structured data. All Belgians already have an digital ID.  
** In Belgium patients already have an individual PHR which contains partially structured data. All Belgians already have an digital ID.  
** In Switzerland Anne has to go the post office.  
** In Switzerland Anne has to go the post office.  
** Joao mentions that a product catalogue is important. Without this you cannot make a complete medication schema.
** Joao mentions that a product catalogue is important. Without this you cannot make a concise medication list..
** Beside the medication structure you also need an organization to maintain the medication structure.
** You also need an organization to maintain the medication structure for the catalogue.  
** You have to show him where the market is.  
** This topic is likely to be discussed in Unicom as well. We should approach Unicom to investigate if there is a need for a profile.
** Michael will approach Christian Hay to see if he sees any added value that IHE Pharmacy could contribute.
** Michael will approach Christian Hay to see if IHE Pharmacy could provide any added value
* Our team needs to set up a marketing plan.
** We need to identify the opportunities and work out the business case.
** Nowadays a standard can only be certified if it manages to reach a certain maturity level.
** That means that users have to implement the standard.




 
===Supply (Project lead: Jose)===
* Supply (Project lead: Jose)
* White paper has been reviewed and updated. The documents can be found here:
** White paper has been reviewed and updated. The documents can be found here:
https://drive.google.com/drive/u/2/folders/1Q6gztuPrsXTa0qQWcAxadOoZUsOOfnUr
https://drive.google.com/drive/u/2/folders/1Q6gztuPrsXTa0qQWcAxadOoZUsOOfnUr
** FHIR material:
*FHIR material:
https://github.com/IHE/pharm-supply
https://github.com/IHE/pharm-supply
http://build.fhir.org/ig/IHE/pharm-supply/index.html
http://build.fhir.org/ig/IHE/pharm-supply/index.html


** a start has been made for the catalogue:
* a start has been made for a product catalogue:
** This has been split and put in a seperate repository/
** The material has been split and put in a seperate repository/
https://github.com/IHE/pharm-catalog/tree/master
https://github.com/IHE/pharm-catalog/tree/master


===Vaccination (Project lead Juergen)===
* Adverse Event Reporting. PAHO might be interested, but are not pushing.
** Interest for a workshop? Jose will organize a workshop for the adverse event


 
=== Medication record (Project lead Jose)===
 
* suspend until new input has been received from Belgium or Italy
 
* Vaccination (Project lead Juergen)
** Adverse Event Reporting. PAHO might be interested, but are not pushing.
** It would be difficult if
** Interest for a workshop? Yes. Jose will organize a workshop for the adverse event
 
 
 
 
* Medication record (Project lead Jose)
** No updates.
** ( in Belgium) currently dormant .
** suspend until new input has been received from Belgium or Italy


* Oncology medication management (Project lead Juergen)
* Oncology medication management (Project lead Juergen)
Line 69: Line 62:


* Jose will discuss a change proposal for the e-Prescription.
* Jose will discuss a change proposal for the e-Prescription.
* This is partly because of Unicom.

Latest revision as of 09:12, 4 February 2022

Minutes

Welcome

  • Participants
    • Trudy Hagg
    • Anne van Berkel
    • Hernany Silva Costa Melo
    • Jose Costa Teixeira
    • Quintin Ligier
    • Sylvia Stein
    • Marc Robberecht
    • Michael Tan
    • Joao Almeida
  • Review and Approve Agenda
  • Minutes of January : these were not made.

Planning Schedule

Work items

Strategy and stakeholder discussion

  • Could the patient be a stakeholder? The aim is to improve the quality of information.
    • In Netherlands a patient program called MedMij is available. This is not centralized. But PHR can certify against FHIR profiles.
    • In Belgium patients already have an individual PHR which contains partially structured data. All Belgians already have an digital ID.
    • In Switzerland Anne has to go the post office.
    • Joao mentions that a product catalogue is important. Without this you cannot make a concise medication list..
    • You also need an organization to maintain the medication structure for the catalogue.
    • This topic is likely to be discussed in Unicom as well. We should approach Unicom to investigate if there is a need for a profile.
    • Michael will approach Christian Hay to see if IHE Pharmacy could provide any added value
  • Our team needs to set up a marketing plan.
    • We need to identify the opportunities and work out the business case.
    • Nowadays a standard can only be certified if it manages to reach a certain maturity level.
    • That means that users have to implement the standard.


Supply (Project lead: Jose)

  • White paper has been reviewed and updated. The documents can be found here:

https://drive.google.com/drive/u/2/folders/1Q6gztuPrsXTa0qQWcAxadOoZUsOOfnUr

  • FHIR material:

https://github.com/IHE/pharm-supply http://build.fhir.org/ig/IHE/pharm-supply/index.html

  • a start has been made for a product catalogue:
    • The material has been split and put in a seperate repository/

https://github.com/IHE/pharm-catalog/tree/master

Vaccination (Project lead Juergen)

  • Adverse Event Reporting. PAHO might be interested, but are not pushing.
    • Interest for a workshop? Jose will organize a workshop for the adverse event

Medication record (Project lead Jose)

  • suspend until new input has been received from Belgium or Italy
  • Oncology medication management (Project lead Juergen)
    • No news.

Any other business

  • Jose will discuss a change proposal for the e-Prescription.
Retrieved from "http://wiki.ihe.net/index.php?title=Pharm_Tech_Minutes_2022.02.04&oldid=127448"